| |
| |
|
| Insider
Information: |
Carmitchel Harry E |
| Relationship: |
Chief Operating Officer |
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
70,000 |
|
|
Indirect Shares
|
18,000 |
|
|
| Direct
Value |
$1,329,300 |
|
|
|
Indirect Value
|
$341,820 |
|
|
| Total
Shares |
88,000 |
|
|
| Total
Value |
$1,671,120 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Osiris Therapeutics, Inc. |
OSIR |
Chief Operating Officer |
2008-12-08 |
70,000 |
2006-12-20 |
18,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2008-12-08 |
4 |
S |
$19.46 |
$136,220 |
D/D |
(7,000) |
70,000 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2008-12-03 |
4 |
S |
$20.35 |
$101,750 |
D/D |
(5,000) |
77,000 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2008-03-05 |
4 |
GD |
$10.36 |
$77,700 |
D/D |
7,500 |
82,000 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2007-11-26 |
4 |
GD |
$10.22 |
$38,325 |
D/D |
3,750 |
89,500 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2007-03-01 |
4 |
OE |
$0.40 |
$8,000 |
D/D |
20,000 |
93,250 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2007-02-28 |
4 |
OE |
$0.40 |
$8,000 |
D/D |
20,000 |
73,250 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2006-12-27 |
5 |
D |
$0.00 |
$0 |
D/D |
(18,000) |
53,250 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2006-12-20 |
4 |
OE |
$0.00 |
$0 |
I/I |
0 |
18,000 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2006-12-20 |
4 |
OE |
$0.40 |
$4,000 |
D/D |
10,000 |
53,250 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2006-10-17 |
4 |
OE |
$15.29 |
$0 |
D/D |
0 |
43,250 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2006-10-17 |
4 |
GD |
$15.29 |
$11,468 |
I/I |
750 |
18,000 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2006-09-27 |
4 |
OE |
$0.40 |
$2,500 |
I/I |
6,250 |
18,750 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2006-09-27 |
4 |
OE |
$0.40 |
$7,500 |
D/D |
18,750 |
43,250 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2006-09-11 |
4 |
GD |
$10.80 |
$140,400 |
D/D |
13,000 |
37,000 |
|
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2006-09-11 |
4 |
OE |
$0.40 |
$10,000 |
D/D |
25,000 |
50,000 |
|
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating OfficerOfficer |
• – – |
2006-08-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,500 |
|
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Chief Operating OfficerOfficer |
• – – |
2006-08-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,500 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
